197 related articles for article (PubMed ID: 16380506)
21. Platycodin D-induced apoptosis through nuclear factor-kappaB activation in immortalized keratinocytes.
Ahn KS; Hahn BS; Kwack K; Lee EB; Kim YS
Eur J Pharmacol; 2006 May; 537(1-3):1-11. PubMed ID: 16631160
[TBL] [Abstract][Full Text] [Related]
22. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
[TBL] [Abstract][Full Text] [Related]
23. Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2005 Feb; 13(2):253-7. PubMed ID: 15643507
[TBL] [Abstract][Full Text] [Related]
24. Suppression of Ewing's sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti vascular endothelial growth factor receptor-2 therapy.
Zhou Z; Bolontrade MF; Reddy K; Duan X; Guan H; Yu L; Hicklin DJ; Kleinerman ES
Clin Cancer Res; 2007 Aug; 13(16):4867-73. PubMed ID: 17699866
[TBL] [Abstract][Full Text] [Related]
25. Absence of HER2/neu gene expression in osteosarcoma and skeletal Ewing's sarcoma.
Thomas DG; Giordano TJ; Sanders D; Biermann JS; Baker L
Clin Cancer Res; 2002 Mar; 8(3):788-93. PubMed ID: 11895910
[TBL] [Abstract][Full Text] [Related]
26. Solamargine upregulation of Fas, downregulation of HER2, and enhancement of cytotoxicity using epirubicin in NSCLC cells.
Liang CH; Shiu LY; Chang LC; Sheu HM; Kuo KW
Mol Nutr Food Res; 2007 Aug; 51(8):999-1005. PubMed ID: 17639997
[TBL] [Abstract][Full Text] [Related]
27. beta-Adrenergic receptors in pediatric tumors: uncoupled beta 1-adrenergic receptor in Ewing's sarcoma.
Whitsett JA; Burdsall J; Workman L; Hollinger B; Neely J
J Natl Cancer Inst; 1983 Oct; 71(4):779-86. PubMed ID: 6312152
[TBL] [Abstract][Full Text] [Related]
28. Characterization of receptors for growth hormone-releasing hormone in human osteosarcomas and Ewing's sarcomas.
Halmos G; Schally AV; Bernardino AL; Varga JL
Int J Oncol; 2006 Aug; 29(2):463-9. PubMed ID: 16820890
[TBL] [Abstract][Full Text] [Related]
29. IL-10 protects mouse intestinal epithelial cells from Fas-induced apoptosis via modulating Fas expression and altering caspase-8 and FLIP expression.
Bharhani MS; Borojevic R; Basak S; Ho E; Zhou P; Croitoru K
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G820-9. PubMed ID: 17030898
[TBL] [Abstract][Full Text] [Related]
30. Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors.
Scotlandi K; Manara MC; Nicoletti G; Lollini PL; Lukas S; Benini S; Croci S; Perdichizzi S; Zambelli D; Serra M; García-Echeverría C; Hofmann F; Picci P
Cancer Res; 2005 May; 65(9):3868-76. PubMed ID: 15867386
[TBL] [Abstract][Full Text] [Related]
31. Adenovirus-E1A gene therapy enhances the in vivo sensitivity of Ewing's sarcoma to VP-16.
Zhou RR; Jia SF; Zhou Z; Wang Y; Bucana CD; Kleinerman ES
Cancer Gene Ther; 2002 May; 9(5):407-13. PubMed ID: 11961663
[TBL] [Abstract][Full Text] [Related]
32. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
[TBL] [Abstract][Full Text] [Related]
33. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
[TBL] [Abstract][Full Text] [Related]
34. Human immunodeficiency virus-1 Tat protein up-regulates interleukin-6 and interleukin-8 expression in human breast cancer cells.
Lee YW; Hirani AA; Kyprianou N; Toborek M
Inflamm Res; 2005 Sep; 54(9):380-9. PubMed ID: 16273337
[TBL] [Abstract][Full Text] [Related]
35. Procollagens as markers for the cell of origin of human bone tumors.
Stern R; Wilczek J; Thorpe WP; Rosenberg SA; Cannon G
Cancer Res; 1980 Feb; 40(2):325-8. PubMed ID: 6927962
[TBL] [Abstract][Full Text] [Related]
36. XAGE-1, a new gene that is frequently expressed in Ewing's sarcoma.
Liu XF; Helman LJ; Yeung C; Bera TK; Lee B; Pastan I
Cancer Res; 2000 Sep; 60(17):4752-5. PubMed ID: 10987281
[TBL] [Abstract][Full Text] [Related]
37. Xg expression in Ewing's sarcoma is of prognostic value and contributes to tumor invasiveness.
Meynet O; Scotlandi K; Pradelli E; Manara MC; Colombo MP; Schmid-Antomarchi H; Picci P; Bernard A; Bernard G
Cancer Res; 2010 May; 70(9):3730-8. PubMed ID: 20388798
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human and mouse breast cancer cells.
Asano T; Kleinerman ES; Zwelling LA; Zhou Z; Fukunaga Y
Acta Oncol; 2005; 44(3):240-7. PubMed ID: 16076696
[TBL] [Abstract][Full Text] [Related]
39. Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model.
Day CP; Rau KM; Qiu L; Liu CW; Kuo HP; Xie X; Lopez-Berestein G; Hortobagyi GN; Hung MC
Cancer Gene Ther; 2006 Jul; 13(7):706-19. PubMed ID: 16514421
[TBL] [Abstract][Full Text] [Related]
40. RNA-based nanoparticle treatment shows promise in Ewing's sarcoma model.
Hede K
J Natl Cancer Inst; 2005 May; 97(9):627. PubMed ID: 15870430
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]